SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: StockDung who wrote (3171)11/8/2000 8:42:23 PM
From: DanZ  Read Replies (2) of 5582
 
Zinc lozenges don't have anything to do with Gum Tech, but the FTC continues to permit Quigley to claim that Cold Eeze reduces the duration of the common cold. I can't find a link to Quigley's December 8, 1999 press release but I do have the text of the first part of it. Should one believe a group of manipulating short sellers or the FTC?

Wednesday December 8, 2:00 pm Eastern Time

Former FTC Associate Director Says FTC Leaves COLD-EEZE(R) Core Claim Untouched

DOYLESTOWN, Pa., Dec. 8 /PRNewswire/ -- A former associate director of the Federal Trade Commission said that a recent FTC review of advertising claims for COLD-EEZE© lozenges left untouched its core claim that the product reduces the duration and severity of common cold symptoms.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext